Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.07.10.602841

Cytosol-living Trypanosoma cruzi amastigotes scavenge cholesterol from host ER and Golgi complex

Abstract

Chagas Disease, caused by the protozoan parasite Trypanosoma cruzi, stands as a prevalent neglected disease in Latin America. The amastigote stage, the replicant intracellular form of the parasite, is a crucial player in infection persistence within vertebrate hosts. The amastigotes exhibit remarkable adaptability regarding the cell type that they infect, being able to modulate their metabolism and growth based on the host cell resources availability. Lipid metabolism emerges as a key determinant of amastigote growth, with a dependency on the host cells lipid resources. While the parasite can synthesize some sterols and fatty acids, it also scavenges these essential components, particularly cholesterol, from the host. Alterations in the hosts cholesterol metabolism, potentially regulated by SREBPs, contribute to increased intracellular cholesterol levels, fostering parasite development. However, the mechanisms underlying cholesterol uptake by amastigotes remained elusive. Here, we investigate the cholesterol trafficking mechanism from host cells to amastigotes by employing a fluorescent cholesterol analog. Using advanced imaging techniques, such as confocal fluorescence microscopy and high-resolution volume electron microscopy we demonstrated that amastigotes internalize extracellular-derived cholesterol, defined the uptake kinetics for cholesterol by amastigotes, and demonstrated that cholesterol is important for amastigote development. Analysis of the interaction of host cell ER with the amastigotes revealed by the presence of membrane contact sites between this organelle and the amastigote plasma membrane. We also showed that amastigotes can take up host ER and Golgi proteins, probably by endocytosis, paving a new mechanism for host cell scavenging of molecules by the parasite. Author SummaryChagas Disease, a widespread yet often overlooked challenge in Latin America, is driven by the parasite Trypanosoma cruzi. Understanding the amastigote stage, the parasites replicative form, is crucial for grasping infection persistence. This study reveals a critical survival strategy - amastigotes adeptly scavenging cholesterol from host cells. We demonstrated that the amastigotes can take up cholesterol from the host and that cholesterol is important for parasite development. Analysis of host cell organelles involved with cholesterol traffic, ER and Golgi, suggested their involvement, establishing crucial conduits for cholesterol acquisition. Deciphering these mechanisms illuminates the intricate interplay between parasite and host, presenting a potential treatment target. The parasites reliance on host cholesterol underscores adaptable growth strategies. This breakthrough deepens Chagas Disease understanding, paving the way for targeted therapeutic interventions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Alcantara, C. d. L., Pereira, M. G., De Souza, W., Cunha-e-Silva, N. L.. 2024-07-12. Cytosol-living Trypanosoma cruzi amastigotes scavenge cholesterol from host ER and Golgi complex. https://doi.org/10.1101/2024.07.10.602841

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A dynamic phosphoproteome reveals stage-specific regulation of cytokinesis in Leishmania

Leishmania parasites undergo extensive morphological and metabolic remodelling during their transition from motile insect promastigotes to non-motile intracellular amastigotes, yet how dynamic protein kinase signalling drives this process remains poorly understood. Here, we present a high-resolution temporal phosphoproteome of L. mexicana promastigote to axenic amastigote differentiation, profiling 16,495 phosphosites on 3,101 proteins across seven developmental time points and identifying 5,795 dynamically regulated sites. This temporal map reveals stage-specific signalling programs, including regulated sites in MPK2 and non-regulated sites in MRK1, protein kinases known to be essential for amastigote differentiation. Using analogue-sensitive (AS) chemical genetics, we show that acute inhibition of either kinase in axenic amastigotes disrupts the spatial coordination of cleavage furrow ingression with nuclear and kinetoplast segregation, revealing essential cytokinesis roles obscured in constitutive gene deletions. Despite generating similar cytokinesis phenotypes, genetic over-expression and cellular localisation analyses demonstrate that MPK2 and MRK1 act through spatially segregated signalling pathways. Time-resolved phosphoproteomics upon MPK2 inhibition places its activity upstream of cytoskeletal remodelling networks. Importantly, we show that the stage-specific requirement for MPK2 is defined by the parasite's morphology: while motile promastigotes tolerate MPK2 inhibition, genetic ablation of flagellar motility sensitises them to loss of MPK2 activity. Thus, flagellar motility acts as a mechanical buffer during promastigote division, explaining why non-motile amastigotes are vulnerable to MPK2 inhibition. Together, our findings provide a systems level framework for Leishmania signalling and demonstrate that cellular architecture and biomechanics dictate protein kinase dependency across developmental stages of the parasite.

cell biology↗

Single-cell Transcriptome-Proteome-PTMome(x8)-Metabolome (scTPPM) co-profiling decodes multimodal regulation during mouse oocyte meiosis

Single-cell multi-omics technology is crucial for comprehensive characterization of cellular molecular features. Despite recent advances in single-cell multi-omics approaches, co-profiling of nucleic acids, proteins, metabolites, and post-translational modifications (PTMs) within the same cell individuals remains major challenges. Here, we developed a single-cell transcriptome, proteome, PTMome, and metabolome (scTPPM) profiling approach, enabling simultaneous analysis of transcriptomes, proteomes, eight types of PTMs (e.g., phosphorylation, methylation, ubiquitination, O_GlcNAc, acetylation, crotonylation, lactylation, and succinylation), and metabolomes in individual cells. We demonstrated the scTPPM's performance in tumor cell lines and oocyte samples, reaching total identification and quantification of 27,668 genes, 4,847 proteins, 1,508 PTM sites, and 680 metabolites in single mouse oocytes. We profiled previously-uncharacterized dynamic crosstalk among the entire metabolic pathways from metabolic enzyme expression and regulation to metabolite-mediated post-translational modifications during oocyte maturation. In summary, scTPPM provided an effective workflow for multi-omics co-profiling in single cells, enabling multi-layered insights into complex regulatory network.

cell biology↗

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗